- Home
- FONR vs ACHV Comparison
FONR vs ACHV Comparison
Compare FONR & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FONR
- ACHV
- Stock Information
- Founded
- FONR 1978
- ACHV N/A
- Country
- FONR United States
- ACHV Canada
- Employees
- FONR N/A
- ACHV N/A
- Industry
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FONR Health Care
- ACHV Health Care
- Exchange
- FONR Nasdaq
- ACHV Nasdaq
- Market Cap
- FONR 76.5M
- ACHV 72.5M
- IPO Year
- FONR 1987
- ACHV N/A
- Fundamental
- Price
- FONR $12.02
- ACHV $2.36
- Analyst Decision
- FONR
- ACHV Strong Buy
- Analyst Count
- FONR 0
- ACHV 3
- Target Price
- FONR N/A
- ACHV $14.33
- AVG Volume (30 Days)
- FONR 14.7K
- ACHV 220.8K
- Earning Date
- FONR 05-14-2025
- ACHV 05-08-2025
- Dividend Yield
- FONR N/A
- ACHV N/A
- EPS Growth
- FONR N/A
- ACHV N/A
- EPS
- FONR 1.17
- ACHV N/A
- Revenue
- FONR $101,570,089.00
- ACHV N/A
- Revenue This Year
- FONR N/A
- ACHV N/A
- Revenue Next Year
- FONR N/A
- ACHV N/A
- P/E Ratio
- FONR $10.39
- ACHV N/A
- Revenue Growth
- FONR N/A
- ACHV N/A
- 52 Week Low
- FONR $12.02
- ACHV $1.84
- 52 Week High
- FONR $18.68
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- FONR 30.46
- ACHV 47.12
- Support Level
- FONR $12.02
- ACHV $1.95
- Resistance Level
- FONR $12.47
- ACHV $2.63
- Average True Range (ATR)
- FONR 0.40
- ACHV 0.23
- MACD
- FONR 0.01
- ACHV 0.05
- Stochastic Oscillator
- FONR 0.00
- ACHV 65.82
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.